
Quetmolimab
CAS No. 2084037-83-0
Quetmolimab( —— )
Catalog No. M36762 CAS No. 2084037-83-0
Quetmolimab is a humanized monoclonal antibody targeting chemokine ligand 1 (CX3CL1) that can be used to study rheumatoid arthritis.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 299 | Get Quote |
![]() ![]() |
5MG | 490 | Get Quote |
![]() ![]() |
10MG | 787 | Get Quote |
![]() ![]() |
25MG | 1132 | Get Quote |
![]() ![]() |
50MG | 1518 | Get Quote |
![]() ![]() |
100MG | 2007 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameQuetmolimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuetmolimab is a humanized monoclonal antibody targeting chemokine ligand 1 (CX3CL1) that can be used to study rheumatoid arthritis.
-
DescriptionQuetmolimab is a humanized anti-CX3CL1 monoclonal antibody. However, CX3CL1 is a chemokine with a modulating effect on chemotaxis and adhesion.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2084037-83-0
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Blaess J, et al. Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage. Ther Adv Musculoskelet Dis. 2020 Dec 16;12:1759720X20959971. ?
molnova catalog



related products
-
Ceftiofur hydrochlor...
Ceftiofur HCl is a cephalosporin antibiotic, used to treat both Gram-positive and Gram-negative bacteria infection.
-
Menaquinone-7
Menaquinone-7 is a vitamin K2 analog, is originally discovered as the anti-hemorrhagic factors. Menaquinone-7 (Vitamin K2-7) is identified as the most bioactive cofactor for the carboxylation reaction of Gla-proteins.
-
MDH1-IN-1
MDH1-IN-1 (5i) is a potent MDH1 inhibitor with an IC50 of 6.79 μM for MDH1 and >40 μM for MDH2.